Progress in Medicinal Chemistry Progress in Medicinal Chemistry Series
Coordonnateurs : Witty David R., Cox Brian
Progress in Medicinal Chemistry, Volume 59, provides a review of eclectic developments in medicinal G139 chemistry. Each chapter is written by an international board of authors, with this release focusing on Small Molecules - Giant Leaps for Immuno-Oncology, Reviewing P2X7, Reviewing ASK1, and Reviewing DNA-encoded libraries.
- Small molecules—Giant leaps for immuno-oncology
- P2X7 receptor antagonists for the treatment of systemic inflammatory disorders
- Discovery and development of ASK1 inhibitors
- An overview of DNA-encoded libraries—A versatile tool for drug discovery
Lisa Kötzner, Bayard Huck, Sakshi Garg and Klaus Urbahns
Christine F. Gelin, Anindya Bhattacharya and Michael A. Letavic
Reginald Brys, Karl Gibson, Tanja Poljak, Steven Van Der Plas and David Amantini
Daniel Madsen, Carlos Azevedo, Iolanda Micco, Lars Kolster Petersen and Nils Jakob Vest Hansen
Everyone interested in the strategy and practice of the preclinical phases of the creation of new medicines. Those wishing to understand the drivers of drug design or expand their knowledge of therapeutic target classes
In 2010 David and several colleagues successfully raised $35M in venture funding to found Convergence Pharmaceuticals, a specialist ion channel company focused on the development of novel treatments for pain, based in Cambridge UK. David presently leads their discovery programme and manages scientific operations within the business.
David is chairman of the Fine Chemicals Group of the Society of Chemical Industry, with responsibility for the delivery of conferences, seminars and training courses for chemists throughout the UK and Europe, and advising parliamentary bodies on matters of relevance to the UK chemical industry.
Since 2008 David has been a STEM ambassador for SETPOINT, introducing school students at both primary and secondary level to the excitement and possibilities of pursuing scientific careers, through workshops, lectures and competitions.
Professor Brian Cox is at University of Sussex, Brighton, UK
- Provides extended, timely reviews of topics in medicinal chemistry
- Contains targets and technologies relevant to the discovery of tomorrow’s drugs
- Presents analyses of successful drug discovery programs
Date de parution : 05-2020
Ouvrage de 260 p.
15x22.8 cm
Thème de Progress in Medicinal Chemistry :
Mots-clés :
Amide; Antagonist; Carboxamide; Cell death; Checkpoint inhibitor; Chemical biology; CNS penetrant; Combination; Combinatorial chemistry; Depression; DNA compatible chemistry; DNA-encoded chemical library; Drug discovery; Endoplasmatic reticulum stress; Fibrosis; IL-1ß; Immune-oncology; Inflammation; Inflammatory disorders; JNK; Kinase inhibitor; Macrophages; MAP3K; Neurodegenerative disorders; Oxidative stress; P2X7; p38; PET ligand; Screening; Small molecule; Small molecule discovery; T-cell